top of page
Search


EU Approves TEVIMBRA for Perioperative Lung Cancer
Published on: LinkedIn (Spencer Knight) The European Commission has approved TEVIMBRA (tislelizumab) from BeOne Medicines, the first PD-1...
Aug 28


Universal Plug-and-Play CAR-T Platform Developed at UChicago
Published on: University of Chicago Medical Center Researchers at the University of Chicago have engineered GA1CAR, a universal CAR-T...
Aug 27


Gene Therapy Restores Hearing in Deaf Children and Adults
Published on: LinkedIn (Spencer Knight) Scientists at Karolinska Institutet have reported a breakthrough gene therapy that restored...
Aug 26


Two FDA Approvals in One Day: Novartis and Novo Nordisk
Published on: LinkedIn (Spencer Knight) The FDA has approved Novartis’ Leqvio (inclisiran) as the first siRNA drug to lower LDL-C without...
Aug 25


First Gene-Edited Islet Cell Transplant Shows Success in Diabetes
Published on: ScienceAlert For the first time, a type 1 diabetes patient has begun producing insulin after receiving gene-edited islet...
Aug 25


Engineered Immune Cells Show Promise for Pulmonary Fibrosis
Published on: Signal Transduction and Targeted Therapy (Nature) A new study demonstrates how engineered immune cells can be programmed to...
Aug 25


FDA Approves First RNA-Targeted Therapy for HAE
Published on: LinkedIn (Spencer Knight) The U.S. FDA has approved DAWNZERA (donidalorsen) from Ionis Pharmaceuticals, the first...
Aug 25


Stem Cell Discovery Could Transform Bone Fracture Healing
Published on: Penn Medicine Researchers at the University of Pennsylvania have identified a muscle-derived stem cell, Prg4+, that can...
Aug 20


Two Landmark Approvals for MASH in One Week
Published on: LinkedIn (Spencer Knight) In just five days, two breakthrough approvals have reshaped treatment for metabolic...
Aug 20


Major Boosts for Cell and Gene Therapy Sector
Published on: LinkedIn (Spencer Knight) The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval...
Aug 19


EU Approves AUCATZYL CAR T Therapy for Adult B-ALL
Published on: Autolus Therapeutics The European Commission has granted marketing authorization for AUCATZYL (obecabtagene autoleucel) to...
Aug 18


FDA Approves First Therapy for Recurrent Respiratory Papillomatosis
Published on: Precigen Investors The U.S. FDA has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first therapy for...
Aug 16


ARM Sector Snapshot Q2 2025: Key Trends in Cell and Gene Therapy
Published on: Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal...
Aug 16


Expert Consensus Aims to Improve Access to CAR T-Cell Therapy
Published on: Cytotherapy CAR T-cell therapy has transformed outcomes for aggressive B-cell Non-Hodgkin lymphoma, yet many eligible...
Aug 14


Stem Cell Therapy Restores Insulin Production in Type 1 Diabetes
Published on: Forbes A clinical trial by Vertex Pharmaceuticals has shown that lab-grown stem cell–derived islet cells can restore...
Aug 14


First MS Patient Receives ‘Off-the-Shelf’ CAR T-Cell Therapy
Published on: Multiple Sclerosis News Today A U.S. trial has treated the first multiple sclerosis (MS) patient with azercabtagene...
Aug 13


Cell Therapy Brings Hope in Deadly Brain Cancer Case
Published on: LinkedIn (Spencer Knight) A groundbreaking case in glioblastoma treatment has emerged from a U.S. clinical trial. Pamela...
Aug 13


Stem Cell Membrane–Coated Nanodrugs Target Microglia in Alzheimer’s Models
Published in ACS Applied Materials & Interfaces Researchers report Gas6-engineered neural stem cell membrane–coated nanoparticles...
Aug 10


How Medicines Unleash the Immune System to Fight Cancer
Published by Harvard Medical School This HMS explainer walks through modern immunotherapy, from checkpoint inhibitors that release immune...
Aug 10


Cytotherapy Launches Podcast with Bruce Levine on CAR-T’s Future and Global Access
Published on Cytotherapy via LinkedIn Cytotherapy’s new podcast features CAR-T pioneer Bruce Levine in conversation with Patrick Hanley....
Aug 8
bottom of page
